A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4
Open Access
- 1 July 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (28) , 16775-16780
- https://doi.org/10.1074/jbc.270.28.16775
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimericPseudomonas exotoxinInternational Journal of Cancer, 1994
- A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signalingCell, 1994
- Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells.The Journal of Experimental Medicine, 1994
- Human Renal Cell Carcinoma Cells Are Sensitive to the Cytotoxic Effect of a Chimeric Protein Composed of Human Interleukin-4 and Pseudomonas ExotoxinCellular Immunology, 1994
- An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxinBioconjugate Chemistry, 1994
- Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-4 ReceptorScience, 1993
- Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 ReceptorScience, 1993
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993
- Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.Journal of Clinical Investigation, 1992
- Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily.The Journal of Experimental Medicine, 1990